CDY.AX
Cellmid Ltd
Price:  
0.05 
AUD
Volume:  
11,309.00
Australia | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CDY.AX WACC - Weighted Average Cost of Capital

The WACC of Cellmid Ltd (CDY.AX) is 7.8%.

The Cost of Equity of Cellmid Ltd (CDY.AX) is 8.25%.
The Cost of Debt of Cellmid Ltd (CDY.AX) is 5.00%.

Range Selected
Cost of equity 6.90% - 9.60% 8.25%
Tax rate 0.60% - 1.00% 0.80%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.7% - 9.0% 7.8%
WACC

CDY.AX WACC calculation

Category Low High
Long-term bond rate 3.7% 4.2%
Equity market risk premium 4.7% 5.7%
Adjusted beta 0.69 0.86
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 9.60%
Tax rate 0.60% 1.00%
Debt/Equity ratio 0.14 0.14
Cost of debt 5.00% 5.00%
After-tax WACC 6.7% 9.0%
Selected WACC 7.8%

CDY.AX's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for CDY.AX:

cost_of_equity (8.25%) = risk_free_rate (3.95%) + equity_risk_premium (5.20%) * adjusted_beta (0.69) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.